Mon. May 25th, 2026
Spread the love

PATH is the leader in global health innovation. An international nonprofit organization, we save lives and improve health, especially among women and children. We accelerate innovation across five platforms-vaccines, drugs, diagnostics, devices, and system and service innovations-that harness our entrepreneurial insight, scientific and public health expertise, and passion for health equity. By mobilizing partners around the world, we take innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs. Together, we deliver measurable results that disrupt the cycle of poor health.

Locations :

  • United States, Washington DC Headquarters Office
  • Nigeria, Abuja Project Office
  • Ghana, Accra Project Office
  • Zambia, Lusaka Country Program Office
  • Tanzania, Dar es Salaam Country Program Office

Responsibilities:

  • Spearhead the technical leadership, design, management, and monitoring of project activity implementation, and ensure adherence to countries’ national technical guidance and global best practices.
  • Provide support to project countries, ensuring high-quality interventions across all technical areas.
  • Manage introduction and scale-up of technical interventions.
  • Support developing project work plans and guide the design of specific, quantifiable performance indicators and targets for core and country programs, and reporting results.
  • Contribute to identifying and scaling-up best practices in malaria diagnosis and case management, malaria in pregnancy, seasonal malaria chemoprevention, and community case management. Understanding and strengthening platforms for malaria service delivery including antenatal care, community health, immunization and nutrition support.
  • Lead documentation and dissemination of project activities.
  • Identify short-term technical assistance needs and assist with recruiting consultants as appropriate.
  • Lead relationships with local and regional partners in support of capacity building efforts.
  • Mentor and guide project teams across geographies and the PATH Malaria portfolio.

Required Skills & Experience:

  • Master’s degree or higher in public health, medical sciences, or other related area.
  • Minimum of 10 years of providing senior technical leadership in designing and implementing malaria control or related programs in service delivery activities, collaborating closely with National Malaria Control Programs and other government and civil society stakeholders in Africa or Asia.
  • Demonstrated international credibility as a leader on malaria diagnosis and/or case management and/or malaria in pregnancy, and/or chemoprevention strategies.
  • Proven experience in working with senior-level representatives of ministries of health and other national government stakeholders, international organizations, other bilateral donor and civil society organizations, and private sector organizations.
  • Demonstrated management, leadership, decision-making, and interpersonal skills.
  • Full professional proficiency in English, with excellent oral and written communications skills required.
  • Ability to interact professionally in French and/or Portuguese an advantage.
  • Experience providing technical leadership in designing and implementing maternal and child health or related programs an advantage
  • Available to travel nationally and internationally up to 25%

Application Dealine June 13, 2025 (14 hours left to apply)

Method of Application

Interested and Qualified candidates should Go:

CLICK HERE TO APPLY 

The post Senior Technical Advisor – REACH Malaria at PATH appeared first on Advert By Dotifi .Com Domains for almajiri.com.ng | Best African Hausa Music Blog, Entertainment ,News and Gossips .

By 9jabook

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.